Edition
Refine your search
  • {{result}}
Browse by Topic
or
Publication Browse
1 - 10 of 12 results (0.83 seconds)
Sort By:
  • The Economic Measurement of Medical Errors
    Disability cost difference per injury 16 Pressure ulcers 17 Data reliance 19 RESULTS 20 Calculations example: ... amount, the vast majority identified (about 87% or $17 billion) was a direct increase in the medical costs ...

    View Description

    • Authors: Jonathan L Shreve, Jill Van Den Bos, EVA BAJTELSMIT ZIEMKIEWICZ, Karan Rustagi, Travis Gray, Michael Halford
    • Date: Jun 2010
    • Competency: External Forces & Industry Knowledge
    • Topics: Economics>Health economics; Health & Disability
  • Pharmacoeconomics: Why ShouldActuaries Care?
    the Medical Device Industry by Robert McCarthy 17 Comparison of Risk Adjusters by Bob Cumming 19 ... this case. The total decision tree has 17 nodes in it for 17 different drug treatments. Figures 1 and ...

    View Description

    • Authors: Jill Van Den Bos
    • Date: Oct 2002
    • Competency: External Forces & Industry Knowledge>Actuarial methods in business operations
    • Publication Name: Health Watch
    • Topics: Economics>Health economics
  • Comparing Measures of Social Determinants of Health to Assess Population Risk
    ................................................ 17 4.1 SUMMARY OF EVIDENCE ....................... ... ................................................ 17 4.2 LIMITATIONS ...............................

    View Description

    • Authors: Rachel Everhart, Travis Gray, Jill Van Den Bos, Society of Actuaries
    • Date: Dec 2020
    • Competency: External Forces & Industry Knowledge
    • Topics: Health & Disability
  • Globalization of the Pharmaceutical Supply Chain: What are the Risks? The FDA’s Difficult Task
    Globalization of the Pharmaceutical Supply Chain: What are the Risks? The FDA’s Difficult Task This ... Lipid-Lowering. annals of Internal medicine, Feb 17, 2009, 150(4):243-254. ContInUED on page 26 26 ...

    View Description

    • Authors: Jill Van Den Bos
    • Date: May 2009
    • Competency: External Forces & Industry Knowledge; Professional Values>Public interest representation; Strategic Insight and Integration>Strategy development; Technical Skills & Analytical Problem Solving>Incorporate risk management
    • Publication Name: Health Watch
    • Topics: Health & Disability>Health care quality; Public Policy; Technology & Applications
  • The Formulary Decision Process:What Are They Doing in There and Can Actuaries Help?
    pharmaceutical benefit trends have increased at rates of 17 percent to 18 percent.ii These pharmaceutical cost ... 2002-2003. Available at www.amcp.org. Accessed February 17, 2004. xvi Neumann, P. Evidence-based and value-based ...

    View Description

    • Authors: Jonathan L Shreve, Jill Van Den Bos, John Watkins, Kristin Reed
    • Date: Mar 2005
    • Competency: Technical Skills & Analytical Problem Solving>Process and technique refinement
    • Publication Name: Health Watch
    • Topics: Health & Disability>Health care
  • The Formulary Decision Process: What Are They Doing in There and Can Actuaries Help?
    pharmaceutical benefit trends have increased at rates of 17 percent to 18 percent.2 The explosive pharmaceutical ... 2002-2003. Available at www.amcp.org. Accessed February 17, 2004. 20Neumann, P. "Evidence-based and value-based ...

    View Description

    • Authors: Jonathan L Shreve, Jill Van Den Bos, John Watkins, Kristin Reed
    • Date: May 2011
    • Competency: Communication>Persuasive communication; External Forces & Industry Knowledge>Actuarial methods in business operations; Leadership>Influence
    • Topics: Economics>Health economics; Health & Disability>Health care
  • Health Section, Issue No. 44, October 2002 Health Section News newsletter
    the Medical Device Industry by Robert McCarthy 17 Comparison of Risk Adjusters by Bob Cumming 19 ... this case. The total decision tree has 17 nodes in it for 17 different drug treatments. Figures 1 and ...

    View Description

    • Authors: Daniel Wolak, Robert Cumming, Steven J Gaspar, Brian Small, Rowen Bell, Jill Van Den Bos, ROBERT FREDERICK MCCARTHY
    • Date: Oct 2002
    • Publication Name: Health Watch
  • Health Section News
    pharmaceutical benefit trends have increased at rates of 17 percent to 18 percent.ii These pharmaceutical cost ... care costs HEALTH SECTION NEWS | MARCH 2005 | 17 SMI parity designates parity for severe mental illnesses ...

    View Description

    • Authors: William Lane, Stephen P Melek, Jonathan L Shreve, Karl Volkmar, Dennis Hare, Corey Berger, Jill Van Den Bos, John Watkins
    • Date: Mar 2005
    • Publication Name: Health Watch
  • Health Plan Provider Network Risk
    19% 0.21% 4% 15 0.67% 0.34% 4% 16 0.15% 0.30% 4% 17 0.24% 0.05% 3% 18 0.28% 0.14% 3% 19 0.23% 0.16% 2% ... Project Health Plan Provider Network Risk Page 17 6/15/2006 From the above assumptions, and assuming ...

    View Description

    • Authors: Thomas Snook, Ross Winkelman, Jill Van Den Bos, Craig J Johns
    • Date: Jun 2006
    • Competency: Technical Skills & Analytical Problem Solving
    • Topics: Health & Disability>Health insurance
  • Perspectives on the Community Living Assistance Services and Support [CLASS] Act
    insurers 16 The impact of the CLASS Act on providers 17 Milliman Research Report Perspectives on the ... Allen Schmitz, and Jill Van Den Bos September 2010 17 If the government and private industry work together ...

    View Description

    • Authors: Robert W Darnell, Dawn E Helwig, Larry Pfannerstill, Allen J Schmitz, Jill Van Den Bos
    • Date: Sep 2010
    • Competency: External Forces & Industry Knowledge
    • Topics: Long-term Care>Long-term care insurance
    • Per Page: